Outset Medical, Inc.
Recent Filings
All 694 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 3/A | — | Mar 4, 2026 |
| 4 | PRIMARY DOCUMENT | Feb 19, 2026 |
| 4 | PRIMARY DOCUMENT | Feb 19, 2026 |
| 4 | PRIMARY DOCUMENT | Feb 19, 2026 |
| 144 | — | Feb 17, 2026 |
| 144 | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 3 | — | Feb 13, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Drexler Karen | — | Sale | 1,548 @ $4.37 | 10,650 | Dec 1, 2025 |
| Trigg Leslie | Chair and CEO | Sale | 916 @ $4.60 | 121,412 | Nov 17, 2025 |
| Nash Marc | EVP Operations R&D & Service | Sale | 247 @ $4.60 | 48,268 | Nov 17, 2025 |
| Brottem John L. | General Counsel | Sale | 388 @ $4.60 | 46,495 | Nov 17, 2025 |
| Nash Marc | EVP, R&D, Operations and Serv. | Award / Grant | 5,617 | 48,515 | Aug 25, 2025 |
| Trigg Leslie | Chair and CEO | Sale | 904 @ $12.88 | 122,328 | Aug 15, 2025 |
| Nash Marc | SVP Operations and R&D | Sale | 243 @ $12.88 | 42,898 | Aug 15, 2025 |
| Brottem John L. | General Counsel | Sale | 383 @ $12.88 | 46,883 | Aug 15, 2025 |
| Nash Marc | SVP Operations and R&D | Award / Grant | 29,676 | 43,141 | Jun 10, 2025 |
| Brottem John L. | General Counsel | Award / Grant | 35,993 | 47,266 | Jun 10, 2025 |